Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
Authors
Keywords
Ganglioside, Melanoma, N glycolyl GM3, Sialidase, Survival
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-08-02
DOI
10.1186/1471-2407-14-560
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells
- (2013) Ana Victoria Casadesús et al. GLYCOCONJUGATE JOURNAL
- Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells
- (2013) Jacky Bonaventure et al. Pigment Cell & Melanoma Research
- Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro
- (2013) J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody
- (2012) Nobuyoshi Hayashi et al. CANCER SCIENCE
- Role of Apollon in Human Melanoma Resistance to Antitumor Agents That Activate the Intrinsic or the Extrinsic Apoptosis Pathways
- (2012) E. Tassi et al. CLINICAL CANCER RESEARCH
- NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth
- (2012) Cristina Tringali et al. INTERNATIONAL JOURNAL OF CANCER
- The Plasma Membrane Sialidase NEU3 Regulates the Malignancy of Renal Carcinoma Cells by Controlling β1 Integrin Internalization and Recycling
- (2012) Cristina Tringali et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NEU3 Sialidase Is Activated under Hypoxia and Protects Skeletal Muscle Cells from Apoptosis through the Activation of the Epidermal Growth Factor Receptor Signaling Pathway and the Hypoxia-inducible Factor (HIF)-1α
- (2012) Raffaella Scaringi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A nine-gene signature predicting clinical outcome in cutaneous melanoma
- (2012) G. Brunner et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- NFATc2 Is a Potential Therapeutic Target in Human Melanoma
- (2012) Valentina Perotti et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melanoma Biomarkers
- (2012) Nikolas K. Haass et al. Molecular Diagnosis & Therapy
- Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides
- (2011) Maiko Miyata et al. CANCER SCIENCE
- Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis
- (2011) Sarah-Jane Schramm et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Regulation of plasma-membrane-associated sialidaseNEU3gene by Sp1/Sp3 transcription factors
- (2010) Kazunori Yamaguchi et al. BIOCHEMICAL JOURNAL
- Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: Results of a phase Ib/IIa study
- (2010) Marta Osorio et al. CANCER BIOLOGY & THERAPY
- GM1 / GD1b / GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line
- (2010) Yu Dong et al. CANCER SCIENCE
- Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains
- (2010) Yuki Ohkawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biomarkers: The Useful and the Not So Useful—An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma
- (2010) Bonnie E. Gould Rothberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling-Dependent MMP-2 Activation
- (2009) J.-W. Liu et al. CANCER RESEARCH
- Sialic acids as regulators of molecular and cellular interactions
- (2009) Roland Schauer CURRENT OPINION IN STRUCTURAL BIOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines
- (2009) Mariano R Gabri et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors
- (2008) Sun-Mi Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3
- (2008) C Tringali et al. CELL DEATH AND DIFFERENTIATION
- Thin layer chromatography of gangliosides
- (2008) Federica Scandroglio et al. GLYCOCONJUGATE JOURNAL
- Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function
- (2008) J. de Leon et al. INTERNATIONAL IMMUNOLOGY
- Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage
- (2008) Frédérique Baruthio et al. PROTEOMICS
- Molecules in the signaling pathway activated by gangliosides can be targets of therapeutics for malignant melanomas
- (2008) Koichi Furukawa et al. PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now